Allogene Therapeutics Inc (ALLO)

01:59 AM

Allogene Therapeutics (NASDAQ:ALLO) Cut to "Sell" at Wall Street Zen - MarketBeat

01:59 AM

Feb 13, 2026

Will Allogene Therapeutics Inc. benefit from geopolitical trendsBreakout Watch & Daily Profit Maximizing Tips - mfd.ru

Feb 13, 2026

Feb 13, 2026

Aug Selloffs: Is Bank of Montreal on track to beat earningsPortfolio Risk Summary & Detailed Earnings Play Alerts - baoquankhu1.vn

Feb 13, 2026

Feb 13, 2026

Bond Watch: Will Allogene Therapeutics Inc stock hit new highs in YEARWeekly Trend Report & Technical Pattern Based Signals - baoquankhu1.vn

Feb 13, 2026

Feb 11, 2026

Will Allogene Therapeutics Inc. outperform small cap indexesEarnings Trend Report & AI Powered Trade Plan Recommendations - mfd.ru

Feb 11, 2026

Feb 11, 2026

Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year? - Yahoo Finance

Feb 11, 2026

Feb 10, 2026

Why Allogene Therapeutics Inc. stock could see breakout soonTreasury Yields & Stock Portfolio Risk Management - mfd.ru

Feb 10, 2026

Feb 09, 2026

Follicular Lymphoma Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsights | AstraZeneca, InnoCare Pharma, Allogene Therapeutics, HUTCHMED, Sound Biologics, Xynomic - Barchart.com

Feb 09, 2026

Feb 09, 2026

Aug Drivers: Will Allogene Therapeutics Inc stock hit new highs in YEAREarnings Risk Report & Free Reliable Trade Execution Plans - baoquankhu1.vn

Feb 09, 2026

Feb 07, 2026

Allogene Therapeutics Approaches a Defining Period for Its Platform - AD HOC NEWS

Feb 07, 2026

Feb 06, 2026

Don't Ignore The Insider Selling In Allogene Therapeutics - 富途牛牛

Feb 06, 2026

Feb 05, 2026

Allogene Therapeutics explores cell therapy trial at ASTCT meeting - Traders Union

Feb 05, 2026

Feb 05, 2026

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences - Yahoo Finance

Feb 05, 2026

Feb 05, 2026

Allogene EVP Roberts sells $63,189 in stock, gains options By Investing.com - Investing.com Canada

Feb 05, 2026

Feb 05, 2026

Allogene Therapeutics CEO Chang David D sells $171k in stock - Investing.com Canada

Feb 05, 2026

Feb 05, 2026

Allogene Therapeutics SVP sells $13k in stock By Investing.com - Investing.com Australia

Feb 05, 2026

Feb 04, 2026

FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug - MSN

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics (NASDAQ:ALLO) EVP Sells $63,189.00 in Stock - MarketBeat

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics (NASDAQ:ALLO) CEO David Chang Sells 95,269 Shares - MarketBeat

Feb 04, 2026

Feb 04, 2026

Insider Selling: Allogene Therapeutics (NASDAQ:ALLO) SVP Sells 7,549 Shares of Stock - MarketBeat

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics (NASDAQ:ALLO) CFO Sells $42,241.76 in Stock - MarketBeat

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics (ALLO) Is Up 24.1% After Extended Cash Runway and CAR T Trial Progress - Yahoo Finance

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics SVP sells $13k in stock - Investing.com

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics SVP sells $40k in stock By Investing.com - Investing.com Canada

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics SVP sells $40k in stock - Investing.com

Feb 04, 2026

Feb 04, 2026

Allogene Therapeutics (NASDAQ:ALLO) SVP Earl Martin Douglas Sells 22,900 Shares - MarketBeat

Feb 04, 2026

Feb 02, 2026

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 02, 2026

Feb 01, 2026

Allogene Therapeutics Gains Following Positive Ratings and Strategic Plans - StocksToTrade

Feb 01, 2026

Feb 01, 2026

Allogene Therapeutics’ Strategic Upgrades Signal Strong Market Potential - timothysykes.com

Feb 01, 2026

Feb 01, 2026

Allogene Therapeutics Sees Potential as Citizens Upgrades to Outperform - StocksToTrade

Feb 01, 2026

Jan 31, 2026

Setup Watch: Is Allogene Therapeutics Inc attractive at current valuation2025 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn

Jan 31, 2026

Jan 31, 2026

Allogene Therapeutics Gears Up for 2026 as Biotech Positivity Fuels Growth Prospects - StocksToTrade

Jan 31, 2026

Jan 30, 2026

Record $2.5B Sector Start Spotlights Clinical Oncology Plays - Baystreet.ca

Jan 30, 2026

Jan 26, 2026

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 26, 2026

Jan 23, 2026

Insider Selling: Allogene Therapeutics (NASDAQ:ALLO) EVP Sells 26,269 Shares of Stock - MarketBeat

Jan 23, 2026

Jan 21, 2026

Take Profit: What are the future prospects of Allogene Therapeutics IncBear Alert & Weekly Momentum Stock Picks - baoquankhu1.vn

Jan 21, 2026

Jan 16, 2026

Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T - ADVFN

Jan 16, 2026

Jan 15, 2026

Insider Trends: What are the future prospects of Allogene Therapeutics IncTrade Risk Report & Fast Moving Stock Watchlists - baoquankhu1.vn

Jan 15, 2026

Jan 15, 2026

Decliners Report: Is AMZE part of any ETF2025 Winners & Losers & Safe Entry Zone Tips - baoquankhu1.vn

Jan 15, 2026

Jan 13, 2026

Earnings Miss: Is Allogene Therapeutics Inc stock a top momentum play - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 13, 2026

Jan 12, 2026

Sell Signal: What are the risks of holding Allogene Therapeutics Inc2025 Technical Overview & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Jan 12, 2026

Jan 12, 2026

Earnings Risk: Will Allogene Therapeutics Inc stock hit new highs in YEARJobs Report & Weekly Market Pulse Alerts - baoquankhu1.vn

Jan 12, 2026

Jan 11, 2026

Allogene Therapeutics Sees Bright Prospects with Upgrades and Awards - StocksToTrade

Jan 11, 2026

Jan 11, 2026

Allogene Therapeutics Sees Optimistic Outlook as Market Interest Grows - timothysykes.com

Jan 11, 2026

Jan 11, 2026

Allogene Therapeutics Stock Surges After Promising Market Developments - timothysykes.com

Jan 11, 2026

Jan 10, 2026

Allogene Therapeutics’ Stock Surges as Analysts Optimistic on Future Outlook - StocksToTrade

Jan 10, 2026

Jan 10, 2026

Allogene Therapeutics Stock Rises Amid Key Developments - StocksToTrade

Jan 10, 2026

Jan 10, 2026

Allogene Therapeutics Stock Upgraded as ALPHA3 Trial Inspires Market Confidence - timothysykes.com

Jan 10, 2026

Jan 10, 2026

Allogene Therapeutics Surges on Positive Analyst Ratings and Arbitration Wins - timothysykes.com

Jan 10, 2026

Jan 09, 2026

Allogene Therapeutics (ALLO) Upgraded by Citizens to Market Outp - GuruFocus

Jan 09, 2026